<code id='C9F683198E'></code><style id='C9F683198E'></style>

<acronym id='C9F683198E'></acronym>

<center id='C9F683198E'><center id='C9F683198E'><tfoot id='C9F683198E'></tfoot></center><abbr id='C9F683198E'><dir id='C9F683198E'><tfoot id='C9F683198E'></tfoot><noframes id='C9F683198E'>

<optgroup id='C9F683198E'><strike id='C9F683198E'><sup id='C9F683198E'></sup></strike><code id='C9F683198E'></code></optgroup>

<b id='C9F683198E'><label id='C9F683198E'><select id='C9F683198E'><dt id='C9F683198E'><span id='C9F683198E'></span></dt></select></label></b><u id='C9F683198E'></u>

~~<i id='C9F683198E'><strike id='C9F683198E'><tt id='C9F683198E'><pre id='C9F683198E'></pre></tt></strike></i>~~

Home» explore» explore

explore

explore

author：knowledge 2025-09-30 09:14:25 Page View：3

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search
Next article： Apple is now the first public company to be valued at $3 trillion

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

Live blog: Hearing on CRISPR

Live blog: Hearing on CRISPR

AdobeTheFoodandDrugAdministrationisconveningameetingofoutsideexpertsonTuesdaytoreviewexa-cel,aCRISPR

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

How neuroscience research could help beat back brain cancer

NewresearchledbyStanfordneuro-oncologistMichelleMonjeshineslightontheelectrochemicalsignalingpathway

read more